Tempus AI, Inc. (NASDAQ:TEM) Receives $54.22 Average Price Target from Analysts

Tempus AI, Inc. (NASDAQ:TEM) has received an average recommendation of “Moderate Buy” from the ten analysts that are currently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price target among brokers that have covered the stock in the last year is $54.22.

Several brokerages have recently issued reports on TEM. Bank of America cut shares of Tempus AI from a “buy” rating to a “neutral” rating and upped their target price for the company from $45.00 to $60.00 in a report on Wednesday, October 2nd. Loop Capital boosted their price target on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research report on Tuesday, October 15th. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and raised their price objective for the stock from $45.00 to $65.00 in a report on Monday, November 11th. Finally, Piper Sandler reissued a “neutral” rating and issued a $70.00 target price (up from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th.

Tempus AI Stock Down 5.1 %

NASDAQ:TEM opened at $50.44 on Friday. Tempus AI has a 1 year low of $22.89 and a 1 year high of $79.49. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The business’s 50-day simple moving average is $53.54.

Institutional Trading of Tempus AI

Institutional investors have recently added to or reduced their stakes in the stock. NEA Management Company LLC purchased a new stake in Tempus AI during the second quarter worth $160,048,000. Novo Holdings A S purchased a new stake in shares of Tempus AI in the 2nd quarter worth about $142,605,000. Revolution Growth Management Company Inc. acquired a new stake in Tempus AI in the 2nd quarter valued at about $128,133,000. ARK Investment Management LLC increased its holdings in Tempus AI by 355.0% during the 3rd quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock valued at $134,604,000 after acquiring an additional 1,855,459 shares in the last quarter. Finally, Alphabet Inc. acquired a new position in Tempus AI during the second quarter worth about $54,289,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.